Related Experiment Videos
The International Society for Heart Transplantation Registry
1Minnesota Heart and Lung Institute, University of Minnesota, Minneapolis.
Insights
Heart transplantation survival has improved with triple-drug immunosuppression. However, cardiac complications are increasing, and congenital heart disease poses a significant risk for heart transplant recipients.
Area of Science:
- Cardiology
- Transplantation Medicine
- Immunology
Background:
- The International Society for Heart Transplantation Registry tracks heart and heart-lung transplant data.
- Significant advancements have been made in heart transplantation outcomes since 1985.
- Congenital heart disease is recognized as a critical factor influencing heart transplant success.
Purpose of the Study:
- To analyze trends in heart and heart-lung transplantation outcomes.
- To identify risk factors and complications in transplant recipients.
- To evaluate the impact of immunosuppression strategies on survival rates.
Main Methods:
- Data collection from the International Society for Heart Transplantation Registry.
- Analysis of approximately 6,500 heart transplant and 344 heart-lung transplant cases.
- Comparative analysis of outcomes based on pre-existing conditions and immunosuppression regimens.
Main Results:
- Operative mortality for heart transplantation has significantly decreased.
- A notable rise in cardiac complications post-heart transplantation has been observed.
- Cystic fibrosis is an increasingly common indication for heart-lung transplantation.
- Triple-drug immunosuppression is associated with improved survival in both heart and heart-lung recipients.
Conclusions:
- While overall survival has improved, particularly with triple-drug immunosuppression, vigilance for cardiac complications is necessary.
- Congenital heart disease remains a significant risk factor requiring careful management in heart transplant candidates.
- The increasing use of heart-lung transplantation for cystic fibrosis highlights its role in managing advanced lung disease.
Abstract:
The Registry for the International Society for Heart Transplantation has collected data on some 6,500 heart transplant recipients and 344 heart-lung recipients. Operative mortality in heart transplantation has decreased substantially since 1985. There has been a recent increase in cardiac complications following heart transplantation. Congenital heart disease is a significant risk factor in heart transplantation. More patients are undergoing heart-lung transplantation for cystic fibrosis. Improved survival is seen with triple-drug immunosuppression in both heart and heart-lung recipients.